expanded activated autologous lymphocyte therapy (Beijing Immunotech Applied Science)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameexpanded activated autologous lymphocyte therapy (Beijing Immunotech Applied Science)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionT lymphocytes stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSmall Cell Lung CarcinomaStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaPending
Originator CompaniesImmunotech Applied Science Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunotech Applied Science Ltd
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A